Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
BMC Cancer ; 13: 470, 2013 Oct 10.
Artigo em Inglês | MEDLINE | ID: mdl-24112563

RESUMO

BACKGROUND: Follow-up rate after a fecal occult blood test (FOBT) is low worldwide. In order to increase the follow-up rate, segmentation of the target population has been proposed as a promising strategy, because an intervention can then be tailored toward specific subgroups of the population rather than using one type of intervention for all groups. The aim of this study is to identify subgroups that share the same patterns of characteristics related to follow-up exams after FOBT. METHODS: The study sample consisted of 143 patients aged 50-69 years who were requested to undergo follow-up exams after FOBT. A classification tree analysis was performed, using the follow-up rate as a dependent variable and sociodemographic variables, psychological variables, past FOBT and follow-up exam, family history of colorectal cancer (CRC), and history of bowel disease as predictive variables. RESULTS: The follow-up rate in 143 participants was 74.1% (n = 106). A classification tree analysis identified four subgroups as follows; (1) subgroup with a high degree of fear of CRC, unemployed and with a history of bowel disease (n = 24, 100.0% follow-up rate), (2) subgroup with a high degree of fear of CRC, unemployed and with no history of bowel disease (n = 17, 82.4% follow-up rate), (3) subgroup with a high degree of fear of CRC and employed (n = 24, 66.7% follow-up rate), and (4) subgroup with a low degree of fear of CRC (n = 78, 66.7% follow-up rate). CONCLUSION: The identification of four subgroups with a diverse range of follow-up rates for CRC screening indicates the direction to take in future development of an effective tailored intervention strategy.


Assuntos
Neoplasias Colorretais/diagnóstico , Idoso , Detecção Precoce de Câncer , Feminino , Seguimentos , Humanos , Masculino , Programas de Rastreamento , Pessoa de Meia-Idade , Sangue Oculto , Fatores de Risco , Fluxo de Trabalho
2.
J Med Invest ; 49(3-4): 147-55, 2002 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-12323004

RESUMO

Lecithin:cholesterol acyltrasferase (LCAT) plays a key role in the cholesterol metabolism-mediated esterification of free cholesterol into the cholesterol ester in normal plasma. Familial LCAT deficiency is frequently associated with anemia. Using biochemical and physiological techniques, the erythrocytes of this patient were investigated to gain an insight into the relationship between the abnormalities of lipid metabolism and erythrocyte membrane fragility. Abnormal erythrocytes, so-called Target cells and/or Knizocytes, were observed at 20% in our patient's erythrocytes. Moreover, the mean corpuscular volume of the patient's cells was 7% greater than that of a normal individual. In the membrane lipids of the patient's erythrocytes, cholesterol and phosphatidylcholine increased, and phosphatidylethanolamine decreased. The electron spin resonance technique with a fatty acid spin probe showed that the membrane fluidity was more elevated than that of normal cells in spite of the increase in cholesterol content and the cholesterol/phospholipid ratio of the membrane of patient's erythrocytes. The patient's abnormally shaped erythrocytes were less deformed than those of the normal individual under high shear stress. The partial depletion of membrane cholesterol from the patient's erythrocytes was demonstrated by incubation with normal plasma with LCAT activity. The increment of transformed erythrocytes during the incubation could be prevented by cholesterol depletion from the patient's erythrocyte membrane. These findings indicate that normochromic anemia of the patient might be caused by erythrocyte fragility resulting from decreased deformity and/or abnormal shape of the cells due to abnormal lipid composition in the membrane.


Assuntos
Deformação Eritrocítica , Membrana Eritrocítica/química , Eritrócitos Anormais/química , Deficiência da Lecitina Colesterol Aciltransferase/sangue , Lipídeos de Membrana/sangue , Fosfatidilcolina-Esterol O-Aciltransferase/fisiologia , Adulto , Colesterol/sangue , Consanguinidade , Deformação Eritrocítica/efeitos dos fármacos , Índices de Eritrócitos , Membrana Eritrocítica/efeitos dos fármacos , Eritrócitos Anormais/efeitos dos fármacos , Feminino , Humanos , Deficiência da Lecitina Colesterol Aciltransferase/genética , Fluidez de Membrana/efeitos dos fármacos , Fragilidade Osmótica/efeitos dos fármacos , Linhagem , Fosfatidilcolina-Esterol O-Aciltransferase/genética , Fosfatidilcolina-Esterol O-Aciltransferase/farmacologia , Fosfatidilcolinas/sangue , Fosfatidiletanolaminas/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA